The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M01 | Antiinflammatory and antirheumatic products | |
| 3 | M01A | Antiinflammatory and antirheumatic products, non-steroids | |
| 4 | M01AE | Propionic acid derivatives | |
| 5 | M01AE03 | Ketoprofen |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 0.15 g |
| PAREN - Parenteral | 0.15 g |
| RECTAL - Rectal | 0.15 g |
| Active Ingredient | Description | |
|---|---|---|
| Ketoprofen |
Ketoprofen is a non-steroidal anti-inflammatory drug. It has anti-inflammatory and analgesic actions. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| OKITASK Film-coated tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| ORUDIS SR Capsule | Pharmaceutical Benefits Scheme (AU) | MPI, EU: SmPC | |
| ORUVAIL Controlled release capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ORUVAIL Gel | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
